62 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Adenoviridae Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Ad Sensor-based Real-time Diagnosis of Adenovirus
Condition: Adenovirus
Intervention: Device: Ad sensor
2 Unknown  Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
3 Available Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Condition: Adenovirus
Intervention: Drug: Brincidofovir
4 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
5 Recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
Condition: Adenovirus Infection
Intervention: Biological: Viralym-A
6 Recruiting A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: genteal gel
7 Recruiting Cytotoxic T Cells to Prevent Virus Infections
Conditions: CMV;   EBV;   Adenovirus Infections
Intervention: Drug: Cytotoxic T lymphocytes (CTLs).
8 Not yet recruiting Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: virus-specific T-Cells
9 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
10 Unknown  Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
Condition: Ischemic Heart Disease
Intervention: Drug: Ad-HGF
11 Recruiting Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
Conditions: Brain Cancer;   Brain Neoplasm;   Glioma;   Glioblastoma;   Gliosarcoma;   Malignant Brain Tumor;   Neoplasm, Neuroepithelial;   Neuroectodermal Tumors;   Neoplasm by Histologic Type;   Neoplasm, Nerve Tissue;   Nervous System Diseases
Interventions: Biological: DNX-2401;   Biological: pembrolizumab
12 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
13 Unknown  Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Condition: Locally Advanced or Metastatic Melanoma
Intervention: Biological: ICOVIR-5
14 Not yet recruiting Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Condition: Tuberculosis
Intervention: Biological: Ad5Ag85A
15 Unknown  TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
16 Recruiting Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors
Condition: Head and Neck Neoplasms
Interventions: Drug: recombinant human endostatin adenovirus;   Drug: Cisplatin injection;   Drug: Paclitaxel injection
17 Recruiting ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus
Condition: Viral Infection
Intervention: Biological: Multi-virus-specific cytotoxic T lymphocytes
18 Recruiting Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation
Conditions: CMV Infection;   EBV;   Adenovirus
Intervention: Biological: Virus specific CTLs
19 Recruiting Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
Conditions: EBV;   CMV;   Adenovirus
Interventions: Drug: CTL for CMV seropositive donors;   Drug: CTL for CMV naïve donors
20 Recruiting A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
Conditions: Adenovirus Infection;   EBV;   Cytomegalovirus Infections;   Cytokine Capture System®;   Allogenic Disease
Intervention: Biological: IFN-γ positive selected T-cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years